Silo Pharma Stock Cash Per Share
SILO Stock | USD 1.85 0.01 0.54% |
Silo Pharma fundamentals help investors to digest information that contributes to Silo Pharma's financial success or failures. It also enables traders to predict the movement of Silo OTC Stock. The fundamental analysis module provides a way to measure Silo Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Silo Pharma otc stock.
Silo |
Silo Pharma OTC Stock Cash Per Share Analysis
Silo Pharma's Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Current Silo Pharma Cash Per Share | 4.45 X |
Most of Silo Pharma's fundamental indicators, such as Cash Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Silo Pharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
Competition |
In accordance with the recently published financial statements, Silo Pharma has a Cash Per Share of 4.45 times. This is 2.3% higher than that of the Biotechnology sector and 2.77% higher than that of the Health Care industry. The cash per share for all United States stocks is 11.18% higher than that of the company.
Silo Cash Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Silo Pharma's direct or indirect competition against its Cash Per Share to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Silo Pharma could also be used in its relative valuation, which is a method of valuing Silo Pharma by comparing valuation metrics of similar companies.Silo Pharma is currently under evaluation in cash per share category among related companies.
Silo Fundamentals
Return On Equity | -0.44 | ||||
Return On Asset | -0.25 | ||||
Operating Margin | (53.47) % | ||||
Current Valuation | (2.06 M) | ||||
Shares Outstanding | 2.84 M | ||||
Shares Owned By Insiders | 6.34 % | ||||
Shares Owned By Institutions | 5.60 % | ||||
Number Of Shares Shorted | 61.39 K | ||||
Price To Earning | 118.39 X | ||||
Price To Book | 0.93 X | ||||
Price To Sales | 77.69 X | ||||
Revenue | 72.1 K | ||||
Gross Profit | 66.26 K | ||||
EBITDA | (3.86 M) | ||||
Net Income | (3.63 M) | ||||
Cash And Equivalents | 8.85 M | ||||
Cash Per Share | 4.45 X | ||||
Current Ratio | 33.28 X | ||||
Book Value Per Share | 2.12 X | ||||
Cash Flow From Operations | (3.22 M) | ||||
Short Ratio | 0.46 X | ||||
Earnings Per Share | (1.18) X | ||||
Target Price | 10.0 | ||||
Beta | 1.35 | ||||
Market Capitalization | 5.6 M | ||||
Total Asset | 7.75 M | ||||
Retained Earnings | (10.87 M) | ||||
Working Capital | 6.91 M | ||||
Net Asset | 7.75 M |
About Silo Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Silo Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Silo Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Silo Pharma based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Silo Pharma. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Complementary Tools for Silo OTC Stock analysis
When running Silo Pharma's price analysis, check to measure Silo Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Silo Pharma is operating at the current time. Most of Silo Pharma's value examination focuses on studying past and present price action to predict the probability of Silo Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Silo Pharma's price. Additionally, you may evaluate how the addition of Silo Pharma to your portfolios can decrease your overall portfolio volatility.
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Stocks Directory Find actively traded stocks across global markets | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |